NCT05395052 2023-09-21FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid TumorsFate TherapeuticsPhase 1 Terminated5 enrolled
NCT02393248 2023-01-06Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101)Incyte CorporationPhase 1/2 Terminated201 enrolled 71 charts
NCT00189579 2007-08-17Addition of Herceptin to a Carboplatin-Paclitaxel Regimen in Patients With Ovarian CancerARCAGY/ GINECO GROUPPhase 2 Terminated45 enrolled